AAFP President to Primary Care Clinicians: On Vaccines—Listen, Reassure, Advocate
The COVID-19 pandemic derailed routine immunizations and triggered a flood of vaccine misinformation beyond the COVID shot. Here, 3 ways to move forward.
It's Vaccination Catch-up Time for Kids: An APB from AAFP President Iroku-Malize
AAFP president Tochi Iroku-Malize, MD, MPH, MBA, urges gentle but persistent efforts among all clinicians to get school-aged children back on vaccination track.
Treatment Approaches for Episodic and Chronic MDD
Experts in psychiatry share their treatment approaches for the management of episodic and chronic MDD.
Treatment Options for MDD
Charles Montano, MD, and Carmen Kosicek, MSN, PMHNP-BC, review currently available treatment options for the management of MDD and criteria used for treatment selection.
Declining Kindergarten Vaccination Rate Leaves 250k Children Unprotected: AAFP President's Perspective
Tochi Iroku-Malize, MD, MPH, MBA, converts the 93% immunization rate for US kindergarteners into raw numbers of children now vulnerable to vaccine-preventable disease.
Prevalence of Hypothyroidism in a Commercially Insured US Population: Limitations and Conclusions
Alex Tessnow M.D. summarizes key data relating to the hypothyroidism in a commercially insured US population, highlighting study limitations and providing his key takeaways.
Prevalence of Hypothyroidism in a Commercially Insured US Population: Results by Region
An expert in hypothyroidism management reviews key prevalence data examined across US regions and examined by treatment type from a recent poster presentation highlighting the prevalence of hypothyroidism in a commercially insured US population.
Prevalence of Hypothyroidism in a Commercially Insured US Population: Age and Gender Results
Dr Alex Tessnow discusses the key prevalence data stratified by gender and age within a longitudinal, retrospective, database study examining the prevalence of hypothyroidism in a commercially insured US population.
Prevalence of Hypothyroidism in a Commercially Insured US Population: Overview and Trial Design
Alex Tessnow M.D. provides a brief overview of the study rationale and design of the recently presented poster highlighting the prevalence of hypothyroidism in a commercially insured US population.
Clinical Implications of Off Target TSH Levels and Importance of Patient Education in Managing Hypothyroidism
Endocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.
Expert Perspectives on TSH Monitoring and Treatment Follow-up to Manage Hypothyroidism
Endocrinology experts share their practical approaches for monitoring TSH levels and providing follow-up to hypothyroidism treatment.
Practical Considerations of Levothyroxine Administration for Hypothyroidism
Experts in endocrinology share their insights into the clinical practicalities of the different types and formulations of levothyroxine treatment in patients with hypothyroidism.
Impact of Diet and Calorie Restriction on TSH Levels in Hypothyroidism
Drs James Hennessey and Antonio Bianco share their insights into the role that diet and calorie restriction can have on thyroid-stimulating hormone[TSH] levels for patients with hypothyroidism.
Levothyroxine Formulation Considerations in Hypothyroidism Management
Antonio Bianco, MD, PhD, shares considerations for using consistent LT4 formulation and highlights the role of pharmacists in maintaining consistent LT4 prescriptions for patients with hypothyroidism.
Key Takeaways for Optimizing TSH Levels in Elderly Patients With Hypothyroidism
Drs James Hennessey and Antonio Bianco talk about the optimization of levothyroxine in elderly patients with hypothyroidism.
Impact of Age and Concomitant Drug Interactions on TSH Levels in Hypothyroidism
James Hennessey, MD, FACP, and Antonio Bianco, MD, PhD, discuss the role of age and concomitant drug interactions in maintaining optimal TSH levels for hypothyroidism management.
Treatment Adherence and Compliance in Maintaining TSH Levels for Hypothyroidism
Experts in endocrinology review the impact of proper and consistent treatment adherence to maintain TSH levels and the role diet and dosing timing plays in managing hypothyroidism.
Key Data on Off Target TSH Levels in Patients with Hypothyroidism
James Hennessey, MD, FACP, provides an overview of clinical trial data for patients with hypothyroidism, highlighting the negative effect and poor health-related consequences of off target TSH levels.
Importance of TSH Target Ranges in Hypothyroidism Management
Experts in endocrinology comment on the importance of maintaining TSH levels in normal target ranges and highlight the prevalence of patients with hypothyroidism not maintaining these targets.
Prevalence of Subclinical vs Overt Hypothyroidism
Drs James Hennessey and Antonio Bianco examine the differences in prevalence between overt and subclinical hypothyroidism.
Prevalence of Primary Hypothyroidism
James Hennessey, MD, FACP, and Antonio Bianco, MD, PhD, discuss the prevalence of hypothyroidism and the role of thyroid hormone replacement therapy in managing the condition.
Monitoring Recommendations for MDD
Charles Montano, MD, and Carmen Kosicek, MSN, PMHNP-BC, provide advice regarding monitoring for adverse events and compliance with different classes of MDD treatment and review suggestions for follow-up and special patient populations.
Perception of MDD in the Healthcare Community
Experts in psychiatry share their thoughts on the perception of MDD within the healthcare community and the implications of this condition being viewed as chronic vs episodic.
How to Keep Family Planning Conversations in Primary Care
How to keep family planning conversations in primary care? First, you have to have them, says UC San Francisco professor of family community medicine, Christine Dehlendorf, MD, MAS.
Contraception Counseling Does Not Include "Shoulds," says Family Planning Expert
Clinician-directed conversations on contraception and family planning remove patients from the center of the visit which is where must be in a shared decision-making model.
Depression and Comorbid Health Conditions
Carmen Kosicek, MSN, PMHNP-BC, and Charles Montano, MD, comment on the interplay between depression and other comorbid psychiatric and medical health conditions as well as the economic impact of MDD.
Impact of MDD Episode Duration and Recurrences
Charles Montano, MD; Carmen Kosicek, MSN, PMHNP-BC; and Gus Alva, MD, DFAPA, review the impact of the duration of MDD episodes and goals of managing episode recurrences.
The Promise of Precision Medicine for Obesity: It Should be Simple
Ordering an obesity phenotype should be as simple and routine as ordering an HbA1c or a lipid panel, says obesity expert Andres Acosta, MD, PhD.
Obesity Phenotype-targeted Treatment Choice Nearly Doubled Weight Loss in Clinical Trials: Investigator Interview
Obesity physician-scientist Andres Acosta, MD, PhD, reviews findings from recent studies he led that suggest true potential for phenotype-focused weight loss intervention.
How to Build an Obesity Phenotype Step-by-Step, with Andres Acosta, MD, PhD
Obesity phenotyping uses a battery of validated tests and procedures to determine the root cause of a patient's disease and then match treatment accordingly.
2 Clarke Drive Cranbury, NJ 08512